Related Experiment Videos
Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells
1Department of Biochemistry, The Cancer Institute, Tokyo, Japanese Foundation for Cancer Research, Japan.
Abstract:
Retinoblastoma cells are resistant to transforming growth factor-beta (TGF-beta) activity due to the absence of TGF-beta binding. To further elucidate the mechanism of TGF-beta resistance, we studied the expression of the TGF-beta receptors and SMADs by using the Y79 and WERI-Rb-1 retinoblastoma cell lines. Binding of 125I-TGF-beta1 to serine/threonine kinase receptor type II (TbetaR-II) and TbetaR-I was not seen in the retinoblastoma cells. TbetaR-II mRNA was not expressed in these cells, but TbetaR-I mRNA was detected. Mutation analysis revealed no mutation in the coding region of the TbetaR-II gene, and TbetaR-II mRNA could be induced after the differentiation of Y79 cells. Smad2, Smad3, and Smad4, which are involved in TGF-beta signaling, were expressed in the retinoblastoma cells. Transcriptional activation of the TGF-beta-responsive genes was not seen by the transfection of either receptor cDNA alone but could be induced by transfection of both TbetaR-II and TbetaR-I. These data suggest that the defect in the TGF-beta response is caused by the lack of TbetaR-II in the retinoblastoma cells. In addition, TbetaR-I may be functionally inactivated in these cell lines.
Insights
Retinoblastoma cells resist transforming growth factor-beta (TGF-beta) due to absent TGF-beta receptor type II (TbetaR-II). Restoring TbetaR-II expression could re-sensitize these cells to TGF-beta signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Retinoblastoma cells exhibit resistance to transforming growth factor-beta (TGF-beta) activity.
- This resistance is linked to an absence of TGF-beta binding, suggesting a defect in the signaling pathway.
Purpose of the Study:
- To investigate the mechanism of TGF-beta resistance in retinoblastoma cells.
- To examine the expression and function of TGF-beta receptors and SMAD proteins in retinoblastoma cell lines.
Main Methods:
- Utilized Y79 and WERI-Rb-1 retinoblastoma cell lines.
- Assessed TGF-beta receptor binding using 125I-TGF-beta1.
- Analyzed receptor and SMAD gene and mRNA expression via mutation analysis and transfection experiments.
Main Results:
- Retinoblastoma cells lacked binding of TGF-beta to serine/threonine kinase receptor type II (TbetaR-II) and TbetaR-I.
- TbetaR-II mRNA was undetectable, while TbetaR-I mRNA was present; no mutations were found in the TbetaR-II coding region.
- Smad2, Smad3, and Smad4 were expressed, but TGF-beta-responsive gene activation required co-transfection of both TbetaR-II and TbetaR-I.
Conclusions:
- The primary defect in TGF-beta response in retinoblastoma cells is the lack of TbetaR-II expression.
- Functional inactivation of TbetaR-I may also contribute to the observed TGF-beta resistance.